National Cancer Institute Thesaurus

Last uploaded: February 23, 2024
Preferred Name

Regadenoson

Synonyms

REGADENOSON

Adenosine, 2-(4-((methylamino)carbonyl)-1H-pyrazol-1-yl)-

Regadenoson

CVT-3146

Definitions

An adenosine derivative and selective A2A adenosine receptor agonist with coronary vasodilating activity. Upon administration, regadenoson selectively binds to and activates the A2A adenosine receptor, which induces coronary vasodilation. This leads to an increase in coronary blood flow and enhances myocardial perfusion. Compared to adenosine, regadenoson has a longer half-life and shows higher selectivity towards the A2A adenosine receptor. This agent is a very weak agonist for the A1 adenosine receptor and has negligible affinity for the A2B and A3 adenosine receptors.

ID

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C74420

CAS_Registry

313348-27-5

Chemical_Formula

C15H18N8O5.H2O

code

C74420

Concept_In_Subset

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C173381

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C173383

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63923

Contributing_Source

FDA

DEFINITION

An adenosine derivative and selective A2A adenosine receptor agonist with coronary vasodilating activity. Upon administration, regadenoson selectively binds to and activates the A2A adenosine receptor, which induces coronary vasodilation. This leads to an increase in coronary blood flow and enhances myocardial perfusion. Compared to adenosine, regadenoson has a longer half-life and shows higher selectivity towards the A2A adenosine receptor. This agent is a very weak agonist for the A1 adenosine receptor and has negligible affinity for the A2B and A3 adenosine receptors.

FDA_UNII_Code

2XLN4Y044H

FULL_SYN

REGADENOSON

Adenosine, 2-(4-((methylamino)carbonyl)-1H-pyrazol-1-yl)-

Regadenoson

CVT-3146

label

Regadenoson

Legacy Concept Name

Regadenoson

NCI_Drug_Dictionary_ID

761605

PDQ_Closed_Trial_Search_ID

761605

PDQ_Open_Trial_Search_ID

761605

Preferred_Name

Regadenoson

prefixIRI

Thesaurus:C74420

Semantic_Type

Pharmacologic Substance

UMLS_CUI

C1698215

subClassOf

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C29707

Delete Subject Author Type Created
No notes to display